期刊
BREAST CARE
卷 8, 期 1, 页码 74-76出版社
KARGER
DOI: 10.1159/000346822
关键词
Breast angiosarconna; Thalidomide; Pathologic complete response
Background: Primary angiosarcoma of the breast is a rare malignancy. Case Report: We report on a 41-year-old female patient who initially presented with locally advanced disease. Core biopsy showed angiosarcoma of the breast, grade 1, CD31-positive. The patient was treated with neo-adjuvant systemic chemotherapy based on cisplatin, doxorubicin, and paclitaxel, given concurrently with thalidomide. After treatment completion, the patient underwent radical mastectomy. Pathologic complete response in the breast and axillary lymph nodes was achieved. The patient has no evidence of disease recurrence 6 months after her initial diagnosis. Conclusion: Anti-angiogenic therapy may be considered as part of the management of primary angiosarcoma of the breast.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据